Clinical Study
Antibacterial-Coated Suture in Reducing Surgical Site Infection in Breast Surgery: A Prospective Study
Table 1
Patient, tumor, and surgical characteristics.
| | Group 1 | Group 2 | P | | n = 92 (%) | n = 98 (%) |
| Patient characteristics |
| Age med (min–max) | 55.5 (14–86) | 54.5 (23–87) | 0.6 | Breast surgery history | 24 (26) | 26 (26) | 0.9 | Radiotherapy history | 1 (1) | 2 (2) | 0.6 | Medical history | | | | Diabetes mellitus | 10 (11) | 7 (7) | 0.4 | Tobacco use | 14 (15) | 20 (20) | 0.4 | High blood pressure | 28 (30) | 25 (25) | 0.4 | BMI med (min–max) | 23.9 (16.4–42.2) | 24.8 (17.5–48) | 0.8 | Corticosteroid therapy | 1 (1) | 1 (1) | 0.9 | Immunodepression | 1 (1) | 1 (1) | 0.9 |
| Surgery |
| Mastectomy | 26 (28) | 28 (28) | 0.9 | Conservative surgery | 56 (61) | 64 (65) | 0.5 | Revision lumpectomy | 3 (3) | 4 (4) | 0.7 | Lymph node biopsy | 23 (25) | 36 (37) | 0.08 | Axillary lymphadenectomy | 34 (37) | 33 (34) | 0.6 | Wire localization | 27 (29) | 41 (42) | 0.07 |
| Tumor characteristics |
| Bilateral | 7 (8) | 14 (14) | 0.14 | Malignant tumor | 65 (76) | 72 (77) | 0.9 | Tumor size med (min–max) | 20.8 (4–65) | 21 (1–70) | 0.8 | Multifocality | 7 (8) | 14 (14) | 0.14 | Number of axillary lymph nodes med (min–max) | 11 (4–23) | 10 (5–22) | 0.4 |
| Neoadjuvant therapies |
| Neoadjuvant chemotherapy | 7 (11) | 5 (7) | 0.4 |
|
|
Group 1: traditional suture material. Group 2: sutures coated with triclosan.
|